Navigation Links
Treatment With VP20621 (Non-Toxigenic Clostridium difficile; NTCD) In A Phase 2 Study Resulted In High Rates Of Colonization And Statistically Significant Reductions In Recurrence Of C. difficile Infection
Date:4/22/2013

ackage inserts at http://www.viropharma.com/Products.aspx; the prescribing information for other countries can be found at www.viropharma.com

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Forward Looking Statements
Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide the Company's current expectations or forecasts of future events. Forward-looking statements in this press release include statements regarding potential therapeutic indication and use, safety, efficacy, tolerability and potential of VP20621, statements that VP20621 may prevent infection by toxin-producing strains of C. difficile and how colonization rates may be increased further. Our actual results could differ materially from those results expressed in, or implied by, these forward-looking statements. The development and commercialization of pharmaceutical products is subject to risks and uncertainties. The safety, colonization and efficacy data described in this press release are preliminary and additional review of the data may reveal additional findings which may not be consistent with this press release. The studies described in this press release represent the results of a Phase 2 study with VP20621 and the results of the study may not be predictive of how VP20621 will perform in future studies. There can be no assurance that that The FDA or EMA may view the data regarding VP20621 as insufficient or inconclusive, request additional data, require additional clinical studies, del
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
8. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014  Publicis Groupe customer engagement agency ... Partner and Healthcare Industry Group Leader, has been featured ... the most inspiring people in the life-sciences industry. Those ... and development, marketing, technology, creativity, strategy and medicine. ... a partner in its leading Rosetta Consulting practice. In ...
(Date:8/21/2014)... BURLINGTON, Mass. , Aug. 21, 2014 /PRNewswire/ ... of COPD,  physicians in Brazil ... to follow clinical guidelines and commonly prescribe long-acting ... regimens, although they do so within current severe ... combinations (FDCs) that are expected to launch in ...
(Date:8/21/2014)... 2014 /PRNewswire-iReach/ -- ScriptPro has been certified by ... Common Security Framework (CSF). According to Russ ... "We appreciate this rigorous, top-to-bottom audit. Security-minded customers ... certification signifies. Our business partners need to know ... CERTIFICATION PROCESS: ScriptPro,s internal security processes and controls ...
Breaking Medicine Technology:Shannon Hartley Shines in PharmaVOICE 100 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3ScriptPro Achieves HITRUST Certification 2
... , , INDIANAPOLIS, Nov. 16 AMD ... laser technology, today announced the addition of Bart Waclawik ... Mr. Waclawik will be responsible for daily global operations, ... the company. Furthermore, he will lead the engineering effort ...
... Nov. 16 Despite the recession, overall growth ... 15 percent in the past two years, according to a ... Solutions. Retail clinic market growth, however, will likely slow to ... 30 percent from 2013-2014, according to the report. , ...
Cached Medicine Technology:AMD LASERS Announces the Addition of Bart Waclawik, New Chief Operating Officer 2Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 2Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 3Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 4
(Date:8/21/2014)... Recently, Top10BestSEOHosting.com has compared many professional SEO ... one of the most reliable suppliers for webmasters who ... been a boom in websites in recent years, and ... the number of web hosting companies that offer a ... HostMonster has been providing hosting solutions to thousands of ...
(Date:8/21/2014)... Recently, Skmen.com, a distinguished garment supplier, has updated ... girls’ casual dresses . From today until August 31, all ... off) when they are shopping at the company’s online store. ... according to the newest quality standards; they are guaranteed to ... dresses, worldwide ladies can also access the other cheap items ...
(Date:8/21/2014)... Lake City, Utah (PRWEB) August 21, 2014 ... ) is pleased to announce the addition of ... over 30 years of healthcare management experience, Gillespie ... His experience includes multiple executive management positions with ... Most recently Kerry served as President of Triad ...
(Date:8/21/2014)... (PRWEB) August 22, 2014 Top10BestSEOHosting.com ... and announces that iPage ( http://www.top10bestseohosting.com/go/iPage/ ) is ... in 2014. , The manager of Top10BestSEOHosting.com ... cheap hosting supplier. Actually, these companies have outperformed ... and customer support. People can get the best ...
(Date:8/21/2014)... Fayetteville, Georgia (PRWEB) August 21, 2014 ... amenities and the atmosphere that comes along with it. ... Fayetteville makes sure that such amenities are available. ... lifestyle community in Fayetteville, Georgia and Community Association Management, ... structure from American Parks Company to provide an additional ...
Breaking Medicine News(10 mins):Health News:Best SEO Hosting Suppliers in the Global Market Recommended by Top10BestSEOHosting.com 2Health News:Charming Girls’ Casual Dresses Now Released by Distinguished Garment Company Skmen.com 2Health News:Kerry Gillespie Appointed as Chief Executive Officer of AVEC Health Solutions 2Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3
... , MONDAY, Jan. 3 (HealthDay News) People ... of becoming obese, new study findings show. Researchers at ... from two large U.S. alcoholism surveys conducted in 1991-1992 and ... women with a family history of alcoholism were 49 percent ...
... the U.S has seen a sharp increase in the number ... weeks, gestation. This is approximately 400,000 children each year, comprising ... are treated the same as full-term infants since they are ... that this can be detrimental to a late-preterm infant,s health ...
... Chronic Total Occlusion Summit and Left Main Coronary ... technologies, research findings and new developments in therapeutic ... in chronic total coronary occlusions and left main ... include:, When and why to open a ...
... chemical group to it at a specific site, a protein ... international research team led by scientists at The University of ... of Nature Cell Biology . In addition to ... same deactivation of the enzyme called EZH2 is necessary for ...
... 2011 For the first time, universal standards to ... medication labels to reflect how patients read and understand ... These labels can vary significantly from pharmacy to pharmacy, ... for the safe use of medications. The new standards, ...
... Philadelphia, PA, January 3, 2011 Postoperative adhesions are ... been used in the hopes of preventing these adhesions ... article in the December 2010 issue of the ... American Association of Pediatric Ophthalmology and Strabismus, a team ...
Cached Medicine News:Health News:Family History of Alcoholism May Raise Obesity Risk 2Health News:Care of late-preterm preemies may be insufficient 2Health News:Care of late-preterm preemies may be insufficient 3Health News:Protein wields phosphate group to inhibit cancer metastasis 2Health News:Universal standards proposed for prescription container labels to help reduce medication misuse 2Health News:Universal standards proposed for prescription container labels to help reduce medication misuse 3Health News:Use of amniotic membrane may cause complications in strabismus surgery 2
... Products are kept in ... are offered as 1-piece ... or extra long lengths. ... insulation, flush ports, rotating ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
Medicine Products: